Close Menu

Gates Foundation

Stopped It

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

At the Economist and his own site, Bill Gates discusses the scientific advances needed to address the pandemic and what comes next.

The method can be used with isothermal amplification and paper-based readouts to detect infectious disease drug resistance in low-resource areas.

For the Accelerator

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

And Then for All

NIH Director Francis Collins describes at Forbes how the agency is working with the Bill & Melinda Gates Foundation to develop gene-based treatments for sickle cell disease and HIV for sub-Saharan Africa.

According to the Seattle Times, the Bill & Melinda Gates Foundation is to enable home testing kits for SARS-CoV-2 to the Seattle area.

The funding comes from the Bill and Melinda Gates Foundation, which previously provided the company with $500,000 for the test's initial development.

The Seattle startup is looking to partner with pharmaceutical companies and offer its yeast fusion sequencing technology as a contracted research service.

With funding from the Bill and Melinda Gates Foundation, the Biohub will help implement metagenomic sequencing for infectious disease projects in 10 countries.

The funding will be used to develop a platform to identify species and strains of bacteria that cannot be cultured or detected with standard methods.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.